Cronos Group Inc vs SoundHound AI Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while SoundHound AI Inc trades at $5.6 (market cap $2.45B). The key difference: SoundHound AI Inc is far larger — about 2.1× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and SoundHound AI Inc for 23 Days on average.
| CRON | SOUN | |
|---|---|---|
Market Cap | $1.18B | $2.45B |
Volume | 968,037 | 16,881,989 |
Sector | Health | Technology |
52-Week High | $3.55 | $21.40 |
52-Week Low | $2.30 | $5.52 |
Typical Hold Time | 22 Days | 23 Days |
Enterprise Value | $387.62M | $2.25B |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
SoundHound AI (SOUN) trades at $5.63, down 1.57% today, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth ($169M in 2025, projected $203M in 2026) but significant net losses (-$14M in 2025, -$137M projected in 2026). Recent developments include expansion into banking AI agents and the OASYS Edge embedded architecture launch for vehicles and smart devices (GlobeNewsWire, September 24, 2026).
Investment outlook balances high growth potential against substantial profitability challenges. Analyst consensus is bullish with a $9.33 price target (75% buy ratings), but negative cash flow from operations and insider selling pose near-term risks. The stock's success depends on converting revenue growth to profitability while managing integration risks from acquisitions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →